A muscled up Moderna finally joins the COVAX crew, pledging 500M doses for low-income countries
Days after turbocharging its Covid-19 vaccine manufacturing capacity to the tune of 3 billion doses per year, Moderna announced Monday it has struck a deal with Gavi, the vaccine alliance, to supply up to 500 million doses of its shot to the lowest income countries by the end of next year.
The discussions date back at least to last October, when Moderna told investors about ongoing discussions with COVAX “on a tiered pricing proposal for purchasing mRNA-1273.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.